PriMed Pharmaceuticals的封面图片
PriMed Pharmaceuticals

PriMed Pharmaceuticals

制药业

Eatontown，NJ 601 位关注者

NABP Accredited Drug Distributor

关注

关于我们

PriMed Pharmaceuticals provides price driven opportunities to our partnering customers. PriMed is contracted with over 35 manufacturing trading partners in order to provide a wide array of generic items are below market costs to increase our customers profit margins. WHO WE ARE PriMed Pharmaceuticals, located in Central New Jersey, is a secondary generic Rx distributor focusing business with community and independent pharmacy. Our attention to market pricing, item demand, and consistent savings has helped PriMed become a fast growing secondary option for our customers. SERVICES At PriMed Pharmaceuticals, our customer’s needs, desires, and requests are paramount. Any and all orders, inquiries, or concerns are met immediately by our staff of highly trained professionals. For as our slogan states, “Your Business is Our Concern.” COMMITMENT TO CUSTOMERS Each and every member of the PriMed family is intimately aware that the success of our customers drives the success of our business. We, therefore, commit the utmost energy and concern to servicing our customers at the highest level. We THANK OUR CUSTOMERS for their continued patronage and support.

网站
https://www.primedrx.com
所属行业
制药业
规模
11-50 人
总部
Eatontown，NJ
类型
私人持股
创立
2013
领域
Pharmaceutical Sales、Medical Distribution、Independent Pharmacy、Community Pharmacy、Regional chain pharmacy、OTC Products和Medical Supplies

地点

PriMed Pharmaceuticals员工

查看全部员工

动态

  • These are not new revelations for those of us in the supply chain, especially our retail pharmacy customers. These are acts that have been perpetrated by the #PBMafia for decades. They are just recently being investigated & brought to light. Thank you The New York Times, and I hope you continue to report on these, in my opinion, criminal acts.

    查看Robert Zirkelbach的档案
    Robert Zirkelbach

    Chief Public Affairs Officer & Head of Strategic Initiatives at PhRMA

    The New York Times?pulled back the curtain on the shady practices of PBMs. These middlemen decide what medicines patients can get and at what cost.?They pocket savings meant for patients and are “driving up drug costs for millions of people, employers and the government.” Policymakers must act now. More: https://lnkd.in/ecGHeBKD ?

    • 该图片无替代文字

相似主页

查看职位